Concussion Market Report 2026

Concussion Market Overview

• Concussion market size has reached to $8.2 billion in 2025 • Expected to grow to $10.43 billion in 2030 at a compound annual growth rate (CAGR) of 5% • Growth Driver: Rise In Prevalence Of Neurological Diseases • Market Trend: Advancements In Rapid Biomarker-Based Concussion Diagnostics • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Concussion Market?

A concussion is a type of traumatic brain injury (TBI) that occurs when the brain experiences a sudden jolt or blow to the head or body, causing the brain to move rapidly back and forth within the skull. This medical condition can temporarily impair brain function and disrupt normal neurological processes. The main types of concussion assessments are diagnosis and treatment. Diagnosis is the identification of a medical condition or disease based on an evaluation of symptoms, medical history, and diagnostic tests. They are diagnosed using various devices, such as imaging devices, magnetic resonance imaging (MRI) devices, X-rays, computed tomography, monitoring devices, and others. They are used by various end-users, such as hospitals and clinics, diagnostic centers, medical camps, and others.

What Is The Concussion Market Growth Forecast?

The concussion market size is expected to see strong growth in the next few years. It will grow to $10.43 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing adoption of ai-assisted concussion diagnostics, rising focus on long-term brain health monitoring, expansion of remote patient monitoring solutions, growing investment in neurorehabilitation technologies, increasing demand for personalized concussion management. Major trends in the forecast period include increasing adoption of advanced neuroimaging tools, rising use of digital cognitive assessment platforms, growing integration of wearable monitoring devices, expansion of multidisciplinary rehabilitation approaches, enhanced focus on early and accurate diagnosis.

What Is The Driver Of The Concussion Market?

The rise in the prevalence of neurological diseases is expected to propel the growth of the concussion market going forward. Neurological diseases are a broad category of medical conditions that affect the nervous system, which includes the brain, spinal cord, and peripheral nerves. Neurological diseases, particularly those associated with traumatic brain injuries, often involve concussions as an initiating factor or exacerbating event, contributing to the development, progression, or complications of conditions such as chronic traumatic encephalopathy (CTE) or post-concussion syndrome. For instance, in February 2023, according to the World Health Organization (WHO), a US-based intergovernmental organization, epilepsy, a neurological disease, affects 5 million people globally, with high-income countries seeing 49 per 100,000 cases, while low- and middle-income countries see up to 139 per 100,000. Therefore, the rise in the prevalence of neurological diseases is driving the growth of the concussion industry.

Key Players In The Global Concussion Market

Major companies operating in the concussion market are Pfizer Inc., Novartis AG, Sanofi SA, Abbott Laboratories, Medtronic plc, Viatris Inc., Zydus Lifesciences Ltd., Integra LifeSciences Corporation, Nihon Kohden Corporation, Raumedic AG, Lupin Limited, NeuroPace Inc., Compumedics Limited, NeuroLogica Corporation, Neural Analytics Inc., NovaSignal Corp., Back Bay Life Science Advisors, BrainScope Company Inc., Neuro Kinetics Inc., ImPACT Applications Inc., NanoDx Inc., Neuren Pharmaceuticals Limited, Advanced Brain Monitoring Inc., ElMindA Ltd., NeurOptics Inc., InfraScan Inc., Neuro Assessment Systems Inc., NeuroTrauma Sciences LLC, SyncThink Inc., Oxeia Biopharmaceuticals Inc., Oculogica Inc., Banyan Biomarkers Inc., Emotiv Inc., BioDirection Inc.

Global Concussion Market Trends and Insights

Major companies operating in the concussion market are focusing on developing innovative solutions, such as rapid point-of-care biomarker blood tests, to meet rising demand driven by greater concussion awareness. Rapid point-of-care biomarker blood tests are quick tests performed near the patient that measure specific blood markers to detect or monitor a condition, helping clinicians make immediate decisions about diagnosis, treatment, or further testing. For instance, in April 2024, Abbott Laboratories, a US-based medical device and diagnostics company, launched a whole blood rapid test for traumatic brain injury (TBI) on its portable i-STAT Alinity platform. This test allows clinicians to assess suspected concussions at the patient’s bedside, providing lab-quality results in just 15 minutes. Previously, TBI tests required plasma or serum samples to be sent to a laboratory, but the new clearance enables faster, on-site evaluation, potentially reducing the need for CT scans and improving timely decision-making in urgent care and other healthcare settings.

What Are Latest Mergers And Acquisitions In The Concussion Market?

In August 2023, Oxeia Biopharmaceuticals Inc., a US-based clinical-stage biotech company, acquired SUN11031, synthetic human ghrelin, from Kinemed Inc. for an undisclosed amount. Through this acquisition, Oxeia is expected to develop SUN11031 as OXE103 for treating concussions and other acute neurotrauma. KineMed Inc. is a US-based pharmaceutical research and development company.

What Defines the Concussion Market?

The concussion market consists of revenues earned by entities by providing concussion services such as consultations, diagnostic tests, imaging studies, CT scans, MRIs, and specialized diagnostic tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The concussion market also includes sales of medications such as pain relievers, anti-nausea medication, or drugs targeting sleep disturbances or mood disorders. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Concussion Market Report 2026?

The concussion market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the concussion industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.